We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
(-1.7%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$38.2M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$37.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$35.3M |
| 4 |
Icon
ICLR
|
+$30.9M |
| 5 |
CELG
Celgene Corp
CELG
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$63.8M |
| 2 |
Danaher
DHR
|
+$50.4M |
| 3 |
AutoZone
AZO
|
+$36.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$33.9M |
| 5 |
Biogen
BIIB
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Healthcare | 24.38% |
| 3 | Financials | 20.66% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IDTI
126
DELISTED
Integrated Device Technology I
IDTI
| $12.9M | 0.25% |
596,601
-137,993
| -19% | -$2.98M |
|
127
NetEase
NTES
$76.5B
| $12.6M | 0.24% |
+434,960
| New | +$11.6M |
|
|
128
Merck
MRK
$324B
| $12.5M | 0.24% |
230,560
-1,137,080
| -83% | -$63.8M |
|
129
Micron Technology
MU
$1.04T
| $12.4M | 0.24% |
656,635
-728,745
| -53% | -$19.4M |
|
130
Ralph Lauren
RL
$22.2B
| $12.1M | 0.23% |
91,686
| – | – |
|
|
OXFD
131
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12.1M | 0.23% |
872,989
+369,978
| +74% | +$5M |
|
132
OneSpan
OSPN
$562M
| $11.8M | 0.23% |
+391,771
| New | +$10.6M |
|
133
F5
FFIV
$22.1B
| $11.8M | 0.23% |
98,114
-141,815
| -59% | -$17.4M |
|
134
Willis Towers Watson
WTW
$27.9B
| $11.7M | 0.23% |
94,375
-17,176
| -15% | -$2.19M |
|
135
Universal Display
OLED
$3.71B
| $11.5M | 0.22% |
221,741
-84,647
| -28% | -$4.27M |
|
136
Teva Pharmaceuticals
TEVA
$35.9B
| $11.3M | 0.22% |
191,000
-329,000
| -63% | -$20.3M |
|
137
Heritage Insurance Holdings
HRTG
$842M
| $11M | 0.21% |
480,000
-170,000
| -26% | -$3.65M |
|
138
Travelers Companies
TRV
$80.8B
| $10.7M | 0.21% |
110,500
-2,000
| -2% | -$205K |
|
139
Bristol-Myers Squibb
BMY
$127B
| $10.6M | 0.2% |
160,000
| – | – |
|
140
Western Digital
WDC
$179B
| $10.5M | 0.2% |
176,729
-114,799
| -39% | -$8.22M |
|
141
Silicon Motion
SIMO
$9.19B
| $10.4M | 0.2% |
301,271
-189,212
| -39% | -$6.17M |
|
142
UBS Group
UBS
$170B
| $10.4M | 0.2% |
498,612
-17,989
| -3% | -$376K |
|
|
CAVM
143
DELISTED
Cavium, Inc.
CAVM
| $10.3M | 0.2% |
150,032
-96,029
| -39% | -$6.73M |
|
|
BCR
144
DELISTED
CR Bard Inc.
BCR
| $10.2M | 0.2% |
+60,000
| New | +$10.3M |
|
145
Cognex
CGNX
$10.3B
| $10.2M | 0.2% |
425,678
-109,638
| -20% | -$2.69M |
|
146
Aflac
AFL
$63.9B
| $10.1M | 0.19% |
325,000
-6,800
| -2% | -$215K |
|
|
WCG
147
DELISTED
Wellcare Health Plans, Inc.
WCG
| $10.1M | 0.19% |
+119,071
| New | +$10.1M |
|
148
Arista Networks
ANET
$219B
| $10M | 0.19% |
1,966,112
-1,153,152
| -37% | -$5.16M |
|
|
XENT
149
DELISTED
Intersect ENT, Inc
XENT
| $9.87M | 0.19% |
+344,578
| New | +$9.03M |
|
150
Delta Air Lines
DAL
$55.9B
| $9.64M | 0.19% |
234,693
-34,355
| -13% | -$1.5M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.
- Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
- Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
- Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
- Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
- Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
- Polar Capital opened 43 new positions and closed 61 in Q2 2015.
- Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.
Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.